Minerva Gimenez-Ribotta

Title: Minerva Gimenez-Ribotta: Innovator in Gene Therapy

Introduction

Minerva Gimenez-Ribotta is a prominent inventor based in Montpellier, France. She has made significant contributions to the field of gene therapy, particularly in the treatment of nervous system pathologies. With a total of 2 patents, her work focuses on innovative methods for delivering nucleic acids to motor neurons.

Latest Patents

Her latest patents include "Adenoviral-vector-mediated gene transfer into medullary motor neurons," which relates to methods and compositions for delivering nucleic acids to motor neurons by administering them to muscle tissue. This invention aims to treat various pathologies of the nervous system, including trauma and neurodegenerative diseases. Another notable patent is "Muscle reinnervation and motor axon sprouting by administering DNA sequences encoding NT-3 and CNTF." This invention also focuses on delivering nucleic acids to motor neurons and addresses similar medical challenges.

Career Highlights

Minerva has established herself as a key figure in her field through her innovative research and development efforts. Her work has the potential to significantly impact the treatment of neurological disorders, showcasing her dedication to advancing medical science.

Collaborations

Minerva has collaborated with notable colleagues, including Françoise Finiels and Jacques Mallet. These partnerships have further enriched her research and contributed to her success as an inventor.

Conclusion

Minerva Gimenez-Ribotta is a trailblazer in gene therapy, with her patents reflecting her commitment to improving treatments for nervous system conditions. Her innovative approaches continue to pave the way for advancements in medical technology.